期刊文献+

基于门诊电子病历数据中老年2型糖尿病患者共病模式分析 被引量:8

Patterns of multimorbidity in middle-aged and elderly type 2 diabetes patients:an electronic outpatient medical record-based analysis
原文传递
导出
摘要 目的了解中老年2型糖尿病患者的共病模式和核心共病,为中医健康管理和临床治疗指南的完善提供科学依据。方法收集2015年1月1日—2019年12月31日在中国中医科学院西苑医院就诊的21425例中老年2型糖尿病患者门诊电子病历数据,采用关联规则挖掘识别2型糖尿病患者常见的二元共病模式,并构建2型糖尿病患者的共病网络,依据网络拓扑学指标判断共病网络中的核心共病。结果21425例中老年2型糖尿病患者中,存在共病者17843例(83.3%);冠心病、充血性心衰、心房颤动、缺血性脑卒中、高血压、血脂异常、动脉硬化、慢性阻塞性肺疾病、哮喘、慢性肾炎、慢性肝炎、类风湿性关节炎、骨关节炎、骨质疏松、抑郁症和焦虑症等16种慢性病共形成了76个有意义的二元共病模式,以支持度排序,最常见的二元共病模式为“冠心病+高血压”(支持度=0.45,提升度=1.31),高血压和冠心病存在于15个二元疾病模式中;在中医就诊的中老年2型糖尿病患者中,共病网络图显示高血压、冠心病、血脂异常、骨质疏松和骨关节炎间的共患率较高,存在复杂的共患关系;共病网络中,节点度和紧密度最大的疾病为冠心病和高血压(节点度=15,紧密度=0.45);结合点度、点权、紧密度和特征向量中心性指标发现,高血压、冠心病、血脂异常、骨关节炎和骨质疏松位于网络的枢纽位置,为中老年2型糖尿病患者的核心共病。结论高血压、冠心病、血脂异常、骨关节炎和骨质疏松是中老年2型糖尿病患者的核心共病,患者和医疗机构应针对这些疾病进行有效预防和管理。 Objective To identify multimorbidity patterns and major comorbidities in middle-aged and elderly patients with type 2 diabetes mellitus(T2DM)for providing evidence to the improvement of traditional Chinese health management and clinical guidelines on multimorbidity.Methods We extracted electronic medical records of 21425 T2DM patients aged≥45 years and seeking medication from January 1,2015 to December 31,2019 in Xiyuan Hospital of the Chinese Academy of Chinese Medical Sciences.Association rule mining was used to identify common binary patterns of multimorbidity in the patients and the multimorbidity network for the T2DM patients was constructed.The major comorbidities were identified according to the network topological index.Results Of all the T2DM patients,83.3%(17843)were diagnosed with 16 other chronic diseases.Among the 16 chronic diseases(including coronary heart disease,congestive heart failure,atrial fibrillation,ischemic stroke,hypertension,dyslipidemia,atherosclerosis,chronic obstructive pulmonary disease,asthma,chronic nephritis,chronic hepatitis,rheumatoid arthritis,osteoarthritis,osteoporosis,depression,and anxiety),totally 76 types of binary patterns of multimorbidity were found,with the most common comorbidity of coronary heart disease and hypertension(support index=0.45,lift index=1.31)according the rank of support index and hypertension and coronary heart disease being the diseases in 15 binary comorbidities.For the T2DM patients treated with traditional Chinese medicine,the multimorbidity network plot suggested higher multimorbidity rates among hypertension,coronary heart disease,dyslipidemia,osteoporosis and osteoarthritis diseases,indicating a complex multimorbidity relationship.In the multimorbidity network constructed,coronary heart disease and hypertension were identified with the greatest node and closeness degree(nodes=15,closeness index=0.45).Based on the degrees of node,strength,closeness and eigenvector centrality,hypertension,coronary heart disease,dyslipidemia,osteoarthritis and osteoporosis were at the key positions in the multimorbidity network constructed and were the major comorbidities among the T2DM patients.Conclusion Among middle-aged and elderly patients with type 2 diabetes mellitus,hypertension,coronary heart disease,dyslipidemia,osteoarthritis and osteoporosis are the major comorbidities and the comorbities need to be concerned for effective prevention and management on multimorbidity in the patients.
作者 闫泽玉 高蕊 孙明月 陈大方 YAN Ze-yu;GAO Rui;SUN Ming-yue(不详;Department of Epidemiology and Biostatistics,School of Public Health,Peking University,Beijing 100191,China)
出处 《中国公共卫生》 CAS CSCD 北大核心 2022年第12期1576-1581,共6页 Chinese Journal of Public Health
关键词 2型糖尿病患者 共病模式 中老年 门诊电子病历 type 2 diabetes patients multimorbidity pattern middle-aged and elderly population outpatient electronic medical record
  • 相关文献

参考文献8

二级参考文献63

  • 1吴艳婷,王颖,徐谦.2型糖尿病合并骨质疏松的研究进展[J].世界最新医学信息文摘,2019,0(76):97-98. 被引量:6
  • 2李灿东,魏佳,陈淑娇.中医健康管理的业态与服务模式[J].中华中医药杂志,2019,34(12):5768-5770. 被引量:26
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5233
  • 4Arakawa M,Mita T,Azuma K,et al.Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist,exendin-4[J].Diabetes,2010,59(4):1030-1037.
  • 5Emerging Risk Factors Collaboration,Sarwar N,Gao P,et al.Diabetes mellitus,fasting blood glucose concentration,and risk of vascular disease:a collaborative meta-analysis of 102 prospective studies[J].Lancet,2010,375(9733):2215-2222.
  • 6Duckworth W,Abraira C,Moritz T,et al.Glucose control and vascular complications in veterans with type 2 diabetes[J].N Engl J Med,2009,360(2):129-139.
  • 7Patel A,Mac Mahon S,Chalmers J,et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358(24):2560-2572.
  • 8Gerstein HC,Miller ME,Byington RP,et al.Effects of intensive glucose lowering in type 2 diabetes[J].N Engl J Med,2008,358(24):2545-2559.
  • 9Egan JM,Bulotta A,Hui H,et al.GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells[J].Diabetes Metab Res Rev,2003,19(4):115-123.
  • 10Rosenstock J,Baron MA,Dejager S,et al.Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes:a24-week,double-blind,randomized trial[J].Diabetes Care,2007,30(6):217-223.

共引文献220

同被引文献101

引证文献8

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部